Compounds > dabigatran

Page last updated: 2024-09-05

dabigatran and sanorg 34006

dabigatran has been researched along with sanorg 34006 in 16 studies

Compound Research Comparison

Studies (dabigatran)	Trials (dabigatran)	Recent Studies (post-2010) (dabigatran)	Studies (sanorg 34006)	Trials (sanorg 34006)	Recent Studies (post-2010) (sanorg 34006)
3,887	261	3,490	89	14	25

Research

Studies (16)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	9 (56.25)	29.6817
2010's	7 (43.75)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hampton, T	1
Money, SR; Stone, WM; Tonnessen, BH	1
Gross, PL; Weitz, JI	1
Nendaz, M; Perrier, A	1
Harenberg, J; Wehling, M	1
Spyropoulos, AC	1
Arya, R; Roberts, LN	1
Halperin, JL	1
Eikelboom, J; O'Donnell, M; Sobieraj-Teague, M	1
Banda, ZK; Benmira, S; Bhattacharya, V	1
Morris, TA	1
Keltai, K; Keltai, M	1
Akl, EA; Barba, M; Kahale, L; Labedi, N; Muti, P; Neumann, I; Schünemann, H; Sperati, F; Terrenato, I	1
Crawford, B; Morimoto, T; Ueda, S; Wada, K	1
Akl, EA; Barba, M; Hakoum, MB; Kahale, LA; Matar, CF; Schünemann, H; Sperati, F; Terrenato, I; Tsolakian, IG; Yosuico, VE	1

Reviews

13 review(s) available for dabigatran and sanorg 34006

Article	Year
Preparing for the post-warfarin generation of antithrombotics. The American journal of managed care, 2004, Volume: 10, Issue:10 Suppl Topics: Atrial Fibrillation; Azetidines; Benzimidazoles; Benzylamines; Clopidogrel; Fibrinolytic Agents; Fondaparinux; Humans; Oligosaccharides; Platelet Aggregation Inhibitors; Polysaccharides; Prodrugs; Pyridines; Stroke; Ticlopidine	2004
The new anticoagulants. Perspectives in vascular surgery and endovascular therapy, 2007, Volume: 19, Issue:3 Topics: Anticoagulants; Antithrombin III; Benzimidazoles; Dabigatran; Humans; Oligosaccharides; Pyridines; Thrombin; Warfarin	2007
New anticoagulants for treatment of venous thromboembolism. Arteriosclerosis, thrombosis, and vascular biology, 2008, Volume: 28, Issue:3 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Injections, Subcutaneous; Male; Maximum Tolerated Dose; Morpholines; Oligosaccharides; Postphlebitic Syndrome; Prognosis; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Survival Analysis; Thiophenes; Treatment Outcome; Venous Thromboembolism	2008
Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIa. Seminars in thrombosis and hemostasis, 2008, Volume: 34, Issue:1 Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Atrial Fibrillation; Azetidines; Benzimidazoles; Benzylamines; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Glycine; Humans; Infusions, Parenteral; Morpholines; Oligosaccharides; Piperazines; Prothrombin; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Thrombin; Thrombosis; Venous Thromboembolism	2008
Brave new world: the current and future use of novel anticoagulants. Thrombosis research, 2008, Volume: 123 Suppl 1 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Dabigatran; Drug Discovery; Factor Xa Inhibitors; Humans; Morpholines; Oligosaccharides; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism	2008
New anticoagulants for prevention and treatment of venous thromboembolism. Current vascular pharmacology, 2010, Volume: 8, Issue:3 Topics: Animals; Anticoagulants; Benzimidazoles; Clinical Trials as Topic; Dabigatran; Drugs, Investigational; Humans; Morpholines; Oligosaccharides; Pyridines; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thromboembolism	2010
What can ongoing clinical trials of anticoagulants demonstrate? Journal of cardiovascular medicine (Hagerstown, Md.), 2009, Volume: 10, Issue:8 Topics: Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Clinical Trials as Topic; Dabigatran; Drugs, Investigational; Humans; Oligosaccharides; Pyridines; Thromboembolism; United States	2009
New anticoagulants for atrial fibrillation. Seminars in thrombosis and hemostasis, 2009, Volume: 35, Issue:5 Topics: Anticoagulants; Atrial Fibrillation; Benzamides; Benzimidazoles; Biotin; Clinical Trials, Phase III as Topic; Dabigatran; Factor Xa Inhibitors; Humans; Morpholines; Oligosaccharides; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Vitamin K	2009
Old versus new anticoagulants: focus on pharmacology. Recent patents on cardiovascular drug discovery, 2010, Volume: 5, Issue:2 Topics: Animals; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Dabigatran; Factor Xa; Factor Xa Inhibitors; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Humans; Morpholines; Oligosaccharides; Polysaccharides; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Thrombin; Warfarin	2010
New synthetic antithrombotic agents for venous thromboembolism: pentasaccharides, direct thrombin inhibitors, direct Xa inhibitors. Clinics in chest medicine, 2010, Volume: 31, Issue:4 Topics: Anticoagulants; Benzamides; Benzimidazoles; beta-Alanine; Dabigatran; Fondaparinux; Humans; Morpholines; Oligosaccharides; Polysaccharides; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Venous Thromboembolism	2010
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer. The Cochrane database of systematic reviews, 2014, Jul-08, Issue:7 Topics: Administration, Oral; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; beta-Alanine; Dabigatran; Heparin, Low-Molecular-Weight; Humans; Neoplasms; Oligosaccharides; Randomized Controlled Trials as Topic; Venous Thromboembolism; Vitamin K	2014
Comparative efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation: A network meta-analysis with the adjustment for the possible bias from open label studies. Journal of cardiology, 2015, Volume: 66, Issue:6 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Azetidines; Benzylamines; Dabigatran; Hemorrhage; Humans; Myocardial Infarction; Odds Ratio; Oligosaccharides; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiazoles; Thromboembolism; Treatment Outcome; Vitamin K	2015
Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer. The Cochrane database of systematic reviews, 2018, 06-19, Volume: 6 Topics: Administration, Oral; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; beta-Alanine; Dabigatran; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Neoplasms; Oligosaccharides; Randomized Controlled Trials as Topic; Venous Thromboembolism; Vitamin K	2018

Other Studies

3 other study(ies) available for dabigatran and sanorg 34006

Article	Year
Agents to control bleeding show promise. JAMA, 2007, Jan-24, Volume: 297, Issue:4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Anticoagulants; Benzimidazoles; Dabigatran; Fibrinolytic Agents; Hematologic Agents; Humans; Oligosaccharides; Pulmonary Embolism; Purpura, Thrombocytopenic, Idiopathic; Pyridines; Receptors, Thrombopoietin; Rituximab; Venous Thrombosis	2007
[Update in hospital internal medicine (2007): a selection]. Revue medicale suisse, 2008, Jan-30, Volume: 4, Issue:142 Topics: Anti-Bacterial Agents; Anticoagulants; Benzimidazoles; Bone Density Conservation Agents; Community-Acquired Infections; Coronary Disease; Dabigatran; Defibrillators, Implantable; Diabetes Mellitus, Type 2; Fractures, Bone; Heart Failure; Heart Neoplasms; Hip Prosthesis; Hospital Departments; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Internal Medicine; Liver Cirrhosis; Oligosaccharides; Osteoporosis; Peritonitis; Pneumonia, Bacterial; Pulmonary Embolism; Pyridines; Quality of Health Care; Risk Factors; Stroke; Teaching; Tomography, X-Ray Computed; Venous Thrombosis	2008
[New anticoagulants in the prevention and treatment of venous thromboembolism]. Orvosi hetilap, 2011, Jun-19, Volume: 152, Issue:25 Topics: Administration, Oral; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Drug Costs; Drugs, Investigational; Factor Xa Inhibitors; Humans; Hungary; Morpholines; Oligosaccharides; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Thrombin; Venous Thromboembolism	2011